Skip to main content

Illinois IGB

Yang Liu

New NIH-funded research aims to improve prostate cancer outcomes

March 30, 2018

University of Illinois at Urbana-Champaign researchers recently received a $1.8 million grant from the National Institutes of Health (NIH) to develop a new assay technology that could determine the effectiveness of cancer drug treatments and aid in disease prognosis. Led by Illinois Bioengineering Assistant Professor Andrew Smith, the team is focusing on detecting nucleic acid-based biomarkers in a single drop of a cancer patient's blood.


March 30, 2018


Related Articles

Subscribe to Yang Liu